This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a ...
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...
The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator ...
The FDA has issued a similar warning for some Answers brand pet food. The manufacturer, Lystn LLC, has not issued a recall, ...
The U.S. FDA issued warnings for ANSWERS Pet Food and Darwin's Natural Pet Products as they contain Salmonella and Listeria.
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...